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Mounting evidence indicates that Merkel cell polyo-
mavirus (MCV), a circular double-strandedDNAvirus,
is a causal factor underlying a highly lethal form
of skin cancer known as Merkel cell carcinoma. To
explore thepossibility thatMCVandother polyomavi-
ruses commonly inhabit healthy human skin, we
developed an improved rolling circle amplification
(RCA) technique to isolatecircularDNAviral genomes
from human skin swabs. Complete MCV genomes
were recovered from 40% of healthy adult volunteers
tested, providing full-length, apparently wild-type
cloned MCV genomes. RCA analysis also identified
two previously unknown polyomavirus species that
we name human polyomavirus-6 (HPyV6) and
HPyV7. Biochemical experiments show that polyo-
mavirus DNA is shed from the skin in the form of
assembled virions. A pilot serological study indicates
that infection or coinfection with these three skin-
tropic polyomaviruses is very common. Thus, at least
three polyomavirus species are constituents of the
human skin microbiome.
INTRODUCTION
The Polyomaviridae are a family of nonenveloped viruses that
carry circular, double-stranded DNA genomes. The family is
named for some members’ ability to induce various types of
tumors in experimentally infected animals. For example, the pol-
yomaviruses BKV and JCV, which persistently infect the urinary
epithelia in a great majority of humans, can cause tumors in
experimentally inoculated rodents (Corallini et al., 1978; Ohsumi
et al., 1986). Although BKV and JCV have been indirectly associ-
ated with the development of various forms of human cancer,
such as prostate cancer and colorectal cancer (respectively),
conclusive proof of a causal relationship between BKV or JCV
and human cancers has remained elusive (reviewed in Abend
et al., 2009; Maginnis and Atwood, 2009). Two more recently
discovered human polyomaviruses, WUV and KIV (Allander
et al., 2007; Gaynor et al., 2007), have also been shown to infect
a majority of humans, but clear links between these two viruses
and human disease, including cancer, have not so far been iden-
tified (reviewed in Dalianis et al., 2009).Cell HThe recent discovery of a fifth human polyomavirus associated
with an unusual form of skin cancer called Merkel cell carcinoma
(MCC) has rekindled research interest in the possibility that
polyomaviruses cause cancer in humans (Feng et al., 2008;
reviewed in Zur Hausen, 2009). DNA sequences of the recently
discovered virus, named Merkel cell polyomavirus (MCV), are
present in about 80% of MCC tumor specimens. Furthermore,
MCV genomes have been shown to be clonally integrated into
the cellular DNA of some MCC tumors and their metastases.
A majority of MCC tumors also display ongoing expression of
the MCV large T antigen oncoprotein (Shuda et al., 2009). Taken
together, the results strongly suggest a causal relationship
between MCV and a majority of MCC cases.
Although serological evidence indicates that most adults
have been immunologically exposed to MCV (Carter et al.,
2009; Kean et al., 2009; Pastrana et al., 2009; Tolstov et al.,
2009), the nature of MCV infection in healthy individuals remains
unclear. Subgenomic fragments of MCV DNA have been
detected in a variety of healthy specimen types, including skin,
saliva, gut, and respiratory secretion samples (Feng et al.,
2008; Loyo et al., 2009; Wieland et al., 2009). At present, only
four full-length MCV genomes have been reported, each of
which was cloned by PCR-based amplification of tumor-derived
DNA (Feng et al., 2008; Katano et al., 2009). All four available
genomes carry truncating mutations in the T antigen gene in
a pattern typical of MCV sequences amplified from tumors
(Shuda et al., 2008). The tumor-derived reference isolate,
MCV-350, also encodes functional defects in its origin of replica-
tion and VP1 capsid protein gene (Kwun et al., 2009; Pastrana
et al., 2009).
The extent to which the complete genomes of tumor-derived
MCV strains are distinct from strains circulating among healthy
individuals is not known. To further explore the tissue tropism
and sequence diversity of MCV in individuals without MCC, we
set out to capture full-length wild-type (WT) MCV DNA shed
from the skin of healthy volunteers. Detection of MCV DNA
was facilitated by a method known as rolling circle amplification
(RCA), a random-primed extension reaction that employs a high-
fidelity DNA polymerase from bacteriophage phi29 to selectively
amplify circular DNA molecules, such as polyomavirus genomic
DNA (reviewed in Johne et al., 2009).
Analysis of cloned RCA products revealed the presence of WT
MCV genomes, as well as a variety of other circular dsDNA mole-
cules, including sequences of a wide variety of human papillo-
mavirus (HPV) species known to infect the skin. Sequencing
of cloned RCA products also revealed the existence of twoost & Microbe 7, 509–515, June 17, 2010 ª2010 Elsevier Inc. 509
Figure 1. Phylogenetic Analysis of Cloned MCV Genomes
Previously reported MCV clones derived from tumor specimens are shown in
bold. MCV isolates identified in this work were named according to subject
identification number followed by an ‘‘a’’ or ‘‘b’’ indicating isolation during
the initial or repeat sampling, respectively. Isolates beginning with the letter
‘‘R’’ were cloned directly from restriction-digested RCA products. Underlined
isolates were derived from individuals born in Asia. Italicized isolates were
derived from individuals born in Europe. Other isolates were derived from indi-
viduals born in North America. See also Figure S1.
Cell Host & Microbe
Polyomaviruses Shed from Human Skinpreviously unknown polyomaviruses. The results draw a striking
parallel between papillomaviruses and polyomaviruses and
reveal an intriguing pair of polyomavirus target species for
studies aimed at uncovering additional links between Polyoma-
viridae and human cancer or other diseases.
RESULTS
Rolling Circle Amplification
Our initial study goal was to isolate full-length, WT MCV genomic
DNA from swabs drawn across the surface of human skin. The
skin of the forehead was chosen based on a recent report by
Wieland and colleagues showing that short MCV PCR products
can be amplified from this easily sampled skin surface (Wieland
et al., 2009). DNA was extracted from the skin swab specimens
and then subjected to random hexamer-primed RCA.
Under ideal circumstances, RCA produces a long polymer of
tandem repeats of any circular template present in the reaction
mixture. RCA reactions performed on DNA extracted from skin
swabs were analyzed by digesting the finished reaction with
restriction enzymes, such as BamHI or EcoRI, that would be
expected to cut known MCV isolates to unit length. Agarose
gel analysis of an initial set of samples showed a smoothly
distributed smear of products, suggesting that the majority of
RCA products were derived from random fragments of linear
cellular DNA, as opposed to discrete circular DNA templates
(data not shown). To overcome this problem, we incorporated
a preprocessing step in which the extracted DNA was digested
with exodeoxyribonuclease V, an enzyme that digests linear
DNA molecules but spares double-stranded circular DNA mole-
cules. This preprocessing step was augmented by the inclusion
of a restriction enzyme that we reasoned would be unlikely to
digest MCV DNA. Like other polyomavirus genomes, available
MCV sequences are relatively deficient in CpG dinucleotide
motifs (White et al., 2009). The restriction enzyme NotI, which
contains two CpG dinucleotides in its eight base pair recognition
motif, was therefore used for the predigestion step. The recogni-
tion sequence of the restriction enzyme SalI, which contains one
CpG motif, also tends not to occur in polyomavirus genomes, so
this enzyme was chosen for the pretreatment step in repeat
sampling experiments (see below).
Swab specimens were collected from a total of 35 study volun-
teers. Sixteen of the volunteers were sampled on two occasions,
roughly 3 months apart. Modified RCA analysis of swab samples
revealed discrete restriction fragment banding patterns for most
individuals. An example of a restriction fragment analysis of skin
swab RCA samples is shown in Figure S1, available online.
It is well established that most humans chronically shed the
DNA of a variety of skin-tropic HPV species from the surface of
their skin (Antonsson et al., 2003). Thus, it was not surprising
to find that a majority of cloned RCA restriction fragments
exhibited varying degrees of homology to HPVs of the skin-tropic
genera beta and gamma (Figure S1 and data not shown). The
complete genome of a previously unknown Gammapapilloma-
virus species was cloned from RCAs of subject 3. The clone was
submitted to the Human Papillomavirus Reference Laboratory
(Heidelberg, Germany) and has been designated HPV type 127.
In addition to HPV-related fragments, a variety of bacterial
plasmid-like sequences were observed. One 5 kb plasmid-like510 Cell Host & Microbe 7, 509–515, June 17, 2010 ª2010 Elsevier Insequence was cloned from RCAs of subject 26. The plasmid-
like sequence was named pMobRep based on the presence of
ORFs encoding proteins with roughly 50% similarity to bacterial
MobA, MobC, and RepA proteins. Overall, approximately 10% of
cloned RCA restriction fragments did not have clear homologs in
BLAST or BLASTX searches.
Analysis of Merkel Cell Polyomavirus Clones
RCA samples from study subjects 17 and 30 displayed prominent
5 kb BamHI or EcoRI restriction fragments. Sequencing of the
cloned restriction fragments revealed them to be complete
MCV genomes (isolates R17a, R17b, and R30a). High-fidelity
PCR, with RCA-amplified material as the template, was used to
clone complete MCV genomes from an additional 12 study sub-
jects. A cumulative total of 14/35 (40%) study subjects yielded
complete MCV genomes at one or both time points (Figure 1).
As expected, each of the MCV isolates encodes full-length
open reading frames for predicted MCV proteins, including the
large T antigen. The one exception is isolate 09b, in which
a 1 base pair insertion results in truncation of the C-terminal 15
amino acids of the predicted small t antigen protein. Each of
the clones encodes an identical consensus T antigen peptide
sequence, with the exception of clone 16b, which differs from
the consensus by only two amino acids. The protein noncoding
control regions (NCCRs) of the MCV clones contain a small
number of single nucleotide substitutions and short insertions
or deletions. Interestingly, the NCCR of isolate 16b encodes a
25 base pair tandem repeat resulting in duplication of a
GGGNGGRR sequence motif that has previously been shown
to enhance transcription and in vitro replication in JCV, SV40,
and a variety of other virus types (Martin et al., 1985). An identicalc.
Figure 2. The Complete Genomic Nucleotide Sequences of Various
Polyomavirus Species Were Used to Construct a Phylogenetic Tree
Human polyomaviruses are underlined. See also Figure S2.
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tumor-derived MCV clone TKS (Katano et al., 2009).
Clones 10b, 16b, and TKS were isolated from individuals born
in Asia. The fact that all three clones are divergent from the main
cluster of MCV isolates derived from individuals born predomi-
nantly in North America and Europe raises the possibility that
different MCV strains are prevalent in geographically distinct
human populations. This would be reminiscent of the situation for
BKV and JCV, whose worldwide sequence divergence patterns
have been shown to resemble ‘‘out of Africa’’ models of prehis-
toric human migration (Yogo et al., 2004; Zhong et al., 2009).
Analysis of the cloned MCV genomes revealed that each
subject who tested positive at both time points shed identical
or nearly identical MCV sequences at both time points (Figure 1).
This suggests that each subject is chronically infected with
a specific MCV isolate. The result also indicates that there was
not extensive cross-contamination among subject samples.
A confounding unknown for serological studies of MCV expo-
sure has been the possibility that distinct MCV genotypes or
serotypes might be disproportionately associated with MCC
tumors. The fact that the four available full-length tumor-derived
MCV clones are interspersed among the apparently WT clones
reported here (Figure 1) argues against the possibility that partic-
ular MCV genotypes are overrepresented in tumors.
Pairwise alignments of the VP1 proteins encoded by the MCV
isolates identified in this study against all available MCV VP1
protein sequences in GenBank revealed a minimum identity of
98.6%. Among human polyomaviruses, only BKV is known to
have subspecies that are serologically distinct (Knowles et al.,
1989). The VP1 protein divergence for MCV isolates is compa-
rable to the divergence seen within BKV serogroups (Figure S1).
The results argue against the existence of distinct serotypes
among available MCV isolates.
Identification of Previously Unknown Human
Polyomaviruses
Sequencing of a 1.6 kb BamHI fragment from the initial RCA
analysis of subject 7 revealed limited homology to the VP2
protein of WU polyomavirus in a BLASTX search. The full
genomic sequence of the previously unknown virus species
was amplified by PCR and cloned. This is the sixth fully
sequenced polyomavirus species of human origin (reviewed in
zur Hausen, 2008). We therefore suggest the name ‘‘human
polyomavirus-6’’ (HPyV6).
To search for additional polyomaviruses similar to HPyV6,
we performed PCR using degenerate PCR primers targeting
conserved portions of various polyomavirus genomes. Since it
did not appear to be possible to design ‘‘universal’’ primers
capable of binding a broad range of polyomavirus species, we
designed partially degenerate primers targeting sequences
conserved between specific pairs of polyomaviruses (see the
Supplemental Experimental Procedures). A primer pair designed
to bind both HPyV6 and WUV successfully amplified a unique
polyomavirus-like sequence. The complete genome of this
second polyomavirus identified by our analysis was amplified
by PCR and was found to be 68% identical to HPyV6 at the
nucleotide level. We named this species HPyV7. The degenerate
primer sets did not detect any additional polyomavirus species
beyond MCV, HPyV6, or HPyV7.Cell HComplete HPyV6 and HPyV7 genomes were cloned from
a total of 5/35 or 4/35 individuals, respectively. As with MCV,
repeat sampling showed that individual subjects continued
to shed a similar or identical HPyV6 or -7 sequence at both
time points (data not shown), again suggesting a chronic clonal
infection.
Phylogenetic comparison of the complete genomes of HPyV6
and 7 to other polyomavirus species shows that the two viruses
identified in this study occupy a distinct clade (Figure 2). HPyV6
and 7 also occupy a longer common branch with WUV and KIV.
This apparent affiliation is attributable primarily to the extreme
divergence of the late regions (VP1 or VP2 capsid genes) of
these four species from all other polyomaviruses (Figure S2).
In contrast to the late regions, the early regions of HPyV6 and
7 are quite distinct from those of WUV and KIV (data not shown).
A possible explanation for this observation could be that the WU/
KI/6/7 cluster arose after an ancient recombination event that
joined the early and late regions of two distantly related polyoma-
virus species.
Polyomavirus DNA Is Shed from the Skin in the Form
of Virions
Productive viral infection is associated with the generation of
progeny virions. To determine whether the polyomavirus DNA
detected in the skin swab specimens was shed in the form of
assembled virions, skin swabs contributed by nine volunteers
were extracted using nondenaturing conditions. A broad-spec-
trum endonuclease was added to the extract with the goal of
digesting any DNA not protected within a virion. The digested
extracts were subjected to an Optiprep step gradient ultracentri-
fugation technique designed to separate virions from free DNA
and other extract components (Buck et al., 2004).
As depicted in Figure 3, qPCR signals for MCV, HPyV6 and
HPyV7 were observed in fractions 2-6 of the swab extractost & Microbe 7, 509–515, June 17, 2010 ª2010 Elsevier Inc. 511
Figure 3. Detection of Virions in Skin Swab Extracts
Polyomavirus virions were extracted from nuclease-treated skin swab speci-
mens and fractionated by ultracentrifugation through Optiprep (panels on
right). DNA was extracted from each fraction (x axes) and subjected to
qPCR analysis with primers targeting MCV, HPyV6, or HPyV7. Purified plasmid
DNA carrying a cloned MCV genome was ultracentrifuged without nuclease
treatment and subjected to qPCR analysis using MCV-specific primers (top
left panel). A parallel gradient in which nuclease was added to MCV plasmid
DNA showed no MCV qPCR signal in any fraction (data not shown). The middle
left panel shows MCV-specific qPCR analysis of a gradient loaded with MCV
virions produced in 293TT cells transfected with recombinant MCV genomic
DNA. The bottom left panel shows an experiment in which MCV VP1-specific
monoclonal antibodies were used to strip MCV DNA out of a pool of fractions
3 and 4 of the swab extract gradient or the MCV-transfected 293TT cell extract
gradient. MCV-specific qPCR measurements in the bottom left panel were
standardized to an isotype control antibody condition. Error bars represent
the standard deviation between three independent experiments.
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and 1.07 g/ml, respectively. This is a relatively broad migration
profile compared to recombinant MCV VP1/VP2 virus-like parti-
cles (VLPs), which typically show an apparent density focused
around 1.21 g/ml (Buck et al., 2004; Pastrana et al., 2009; Tolstov
et al., 2009). A possible explanation for the broad migration
profile is that the viral DNA is protected within virions that
are heterogeneously complexed with relatively buoyant com-
pounds, such as skin-derived lipids or cosmetics. This concept
is consistent with recent observations showing that recombinant
MCV VP1 capsomers can bind buoyant glycosphingolipids in the
setting of sucrose gradients (Erickson et al., 2009).
The swab extract gradient contained a total of roughly two
million MCV genome equivalents and roughly 5000 HPyV6
genome equivalents. Cycle sequencing of the faint PCR prod-
ucts observed in fractions 3, 5 and 6 with the HPyV7-specific512 Cell Host & Microbe 7, 509–515, June 17, 2010 ª2010 Elsevier Inprimer set confirmed an appropriate HPyV7 sequence. However,
the overall signal for this species was too low to allow a confident
interpretation. Gradient analyses of three independent sets of
swab specimens showed similar results (data not shown).
As a positive control for the gradient analysis, we generated
modest yields of MCV virions by transfecting 293TT cells with
recombinant MCV isolate R17a genomic DNA. The MCV virions
produced in transfected 293TT cells showed a focused migra-
tion profile, with a strong peak in fraction 3.
No qPCR signal was detected in a control gradient in which
free MCV isolate R17a plasmid DNA was spiked into a mock
extract containing endonuclease (data not shown). Free MCV
DNA that was not subjected to nuclease treatment remained
predominantly in the upper portion of the ultracentrifuge gradient
(Figure 3), consistent with the greater buoyancy of non-encapsi-
dated DNA in Optiprep.
The datasuggest that the highdensity nuclease-resistantDNA in
the skin swab extracts and transfected cell lysates is in the form of
assembled virions.To confirm this explanation, we performed an
experiment in which monoclonal antibodies specific for the VP1
major capsid protein of MCV (D.V.P., K.A.P, N. C¸uburu, R.M.S.,
and C.B.B., unpublished data) were used to strip MCV DNA out
of Optiprep fraction material. The results, shown in the bottom
left panel of Figure 3, confirm that a majority of the MCV DNA in
the swab extract and 293TT-produced virion gradients is associ-
ated with VP1 protein. Taken together, the results clearly demon-
strate that MCV DNA is shed from the skin in the form of assembled
virions. The high density of a majority of the nuclease-resistant
HPyV6 (and perhaps HPyV7) DNA in Optiprep gradients suggests
that these viruses are also shed in the form of virions.
Serological Analysis of HPyV Exposure
Polyomavirus VP1 proteins typically have the ability to sponta-
neously self-assemble into virus-like particles (VLPs) when
expressed as recombinant proteins. Enzyme-linked immunosor-
bent assays (ELISAs) employing recombinant polyomavirus
VLPs have been widely used to detect virus-specific antibody
responses aroused during natural infection. To develop ELISAs
targeting HPyV6 and HPyV7, the VP1 protein of each virus
species was expressed in transfected 293TT cells and purified
by Optiprep gradient ultracentrifugation. Although the HPyV6
and HPyV7 VP1 proteins migrated to the core fractions of the
gradient where VLPs are typically found, electron micrographs
revealed irregular particles smaller than the 45–50 nm diameters
expected for full-size polyomavirus VLPs (Figure S3). The VP1
subviral particles were of sufficient purity for use in ELISAs.
Full-size murine polyomavirus (MPyV) or MCV-based VLPs
were produced in 293TT cells for use in negative and positive
control ELISAs, respectively (Tolstov et al., 2009).
A set of 95 serum samples that had previously been tested for
reactivity against MCV (Pastrana et al., 2009; Tolstov et al., 2009)
were retested in separate ELISAs against VP1 particles based on
MPyV, MCV, HPyV6, or HPyV7 (Figure 4). Each serum sample
showed a distinct pattern of reactivity to each of the three human
polyomavirus VP1 proteins, suggesting that each ELISA is poly-
omavirus species specific. The 58/95 (61%) rate of seropositivity
for MCV is similar to previous observations for this group of sera
(set ‘‘Commercial Donor’’ reported in Tolstov et al., 2009). Reac-
tivity against HPyV6 was also very common, with 66/95 (69%)c.
Figure 4. Serological Analysis of HPyV6
and -7 Exposure
Serum samples from 95 donors were diluted 1:100
and subjected to ELISA using purified VP1
particles of indicated polyomavirus species. The
optical density (OD) values for a representative
set of 12 samples are shown graphically. A sero-
positivity cutoff value of 0.105 (dotted line) was
chosen to exclude the maximum signal observed
in the MPyV (negative control) ELISA (data not
shown). The table at the bottom of the figure
shows observed frequency of single, double, and
triple seropositivity for the three human polyoma-
virus species, as well as expected frequencies
derived by multiplication of individual frequencies.
See also Figure S3.
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was lower, with 33/95 (35%) subjects scoring seropositive. The
frequency of double seropositivity for pairs of virus species
was similar to frequencies predicted by the products of indi-
vidual frequencies (chart in Figure 4). This suggests that serolog-
ical exposure to each cutaneous polyomavirus species is an
independent variable.
DISCUSSION
It is well established that most humans become infected with
BKV and JCV polyomaviruses during childhood. Both of these
polyomavirus species can chronically infect the stratified epithe-
lial surfaces of the lower urinary tract, where virions are periodi-
cally shed into the urine (Hogan et al., 1980; Boldorini et al., 2005;
Singh et al., 2006). In the current work, we show that virions of
a separate group of polyomavirus species are shed from the
surface of a different stratified epithelial surface, the skin. Our
data suggest that nearly all adults are persistently infected with
one or more of the cutaneous polyomavirus species.
Although known human polyomaviruses appear not to cause
overt clinical symptoms in a great majority of infected individ-
uals, they can cause disease in subjects with impaired immune
function. For example, BKV can induce nephropathy in kidney
transplant recipients, and JCV causes progressive multifocal
leukoencephalopathy, a fatal brain disease that sometimes
strikes immunocompromised individuals (reviewed in Jiang
et al., 2009). Similarly, the observation that risk of MCC increases
dramatically in immunocompromised subjects provided an initial
line of evidence supporting the concept that MCC might be
caused by an infectious agent (Engels et al., 2002; Feng et al.,
2008). By extension, it seems likely that diseases that might be
caused by HPyV6 or HPyV7 would occur at greater frequency
in immunocompromised subjects. Past work establishing causal
links between polyomaviruses and human disease suggests that
possible disease associations could be explored through PCR or
in situ detection of the viral DNA in lesion samples (reviewed in
Buck and Lowy, 2009), or by immunohistochemical detection
of T antigen protein expression in tissue specimens (Shuda
et al., 2009). Quantitative serological analysis using the VP1
ELISA reported here might also be used to identify possible linksCell Hbetween high-titer polyomavirus-specific seroreactivity and
candidate disease states (Carter et al., 2009; Pastrana et al.,
2009; Tolstov et al., 2009).
Several of the MCV isolates reported in this work bear striking
similarity to MCV clones isolated from MCC tumors, with one pair
(16b versus TKS) differing by only three nucleotides in the entire
5.4 kb MCV genome. Analysis of VP1 peptide sequences simi-
larly suggests that all available MCV isolates occupy a single
serotype (Figure S1). WT and tumor-derived MCV isolates also
appear to carry relatively consistent NCCRs. This contrasts
with the complex insertions and deletions that can sometimes
be found in the NCCRs of BKV and JCV isolates derived from
diseased tissues (reviewed in White et al., 2009). Together, the
results argue against the possibility that MCC tumors are caused
by a subset of MCV types distinct from those that commonly
infect healthy individuals.
The chronic shed of polyomavirus virions from the surface
of the skin is strikingly reminiscent of the Papillomaviridae,
a different family of nonenveloped circular dsDNA viruses
that replicate exclusively in keratinocytes of the epidermis and
are transmitted environmentally or via interpersonal contact.
Although the presence of MCV in MCC tumors indicates that
the virus can enter Merkel cells or their epidermal precursors
(Van Keymeulen et al., 2009), the fact that Merkel cells make
up fewer than 1% of cells in the epidermis strongly suggests
that more common epidermal cells, such as keratinocytes or
melanocytes, are involved in the active production of virions.
For papillomaviruses, the production of virions is closely tied
to keratinocyte differentiation (reviewed in Doorbar, 2005).
Consequently, papillomaviruses cannot be propagated in stan-
dard monolayer cell cultures. Although cultured cell monolayers
transfected with recombinant MCV genomes can produce
virions (Figure 3), the overall production rate is very low, aver-
aging only about one virion per cell. Cells transfected with
HPyV6 or HPyV7 genomes appear to yield similarly meager
numbers of virions (data not shown). The results raise the possi-
bility that the life cycles of the cutaneous polyomaviruses are tied
to epidermal differentiation.
The family Polyomaviridae currently contains only one genus,
Polyomavirus. We are not aware of an exact standard for what
constitutes a distinct polyomavirus species, and the assignmentost & Microbe 7, 509–515, June 17, 2010 ª2010 Elsevier Inc. 513
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at least four different conventions. This contrasts sharply with
the situation for the family Papillomaviridae, which has recently
benefitted from the development of a precise set of classification
rules (Bernard et al., 2010; De Villiers et al., 2004). Given the
remarkable range of biological similarities between the two
families—including their apparent capacity to occasionally
undergo interfamilial recombination (Woolford et al., 2007)—we
feel that the application of a papillomavirus-like taxonomic
system to the polyomaviruses could be of great utility. Based
on our understanding of the system, we would suggest that
HPyV6 and HPyV7 be considered two unique species that
occupy a distinct genus-like clade. Since HPyV6 and HPyV7
are the fifth genus-like clade of polyomaviruses known to contain
a human-tropic species, we would suggest the name ‘‘Epsilon-
polyomavirus’’ for their clade. While we are in favor of the idea
that genus designations might ultimately be superimposed on
existing polyomavirus species, it is our view that reassigning
‘‘HPyV#’’ species names to the five previously discovered
human polyomaviruses would be undesirable and would violate
the ICTV’s Code of Virus Classification, sections 2.1 and 3.9
(http://www.ictvonline.org/).
The discoveries of MCV, WUV, and KIV were all facilitated by
the use of high-throughput shotgun sequencing (Allander et al.,
2007; Feng et al., 2008; Gaynor et al., 2007). Since the initial
goal of the current study was to capture full-length MCV clones,
we elected to rely on traditional plasmid-based cloning tech-
niques. These methods severely limited the throughput of
our analysis, and at least a third of the restriction fragments
visualized by agarose gel electrophoresis could not readily be
cloned. The improved random-primed RCA method reported
here should be adaptable for use with modern high-throughput
sequencing methods, potentially allowing the future develop-
ment of a more comprehensive catalog of polyomaviruses and
other circular microbial DNA molecules commonly present on
various human skin and mucosal surfaces.
EXPERIMENTAL PROCEDURES
Subjects and Sample Collection
Employees of the National Cancer Institute (NCI)’s Laboratory of Cellular
Oncology were recruited for the study under National Institutes of Health
(NIH) protocol 09-C-N219. Each volunteer was informed about the study
and invited to consent to self-sampling by drawing a sterile wooden cotton-tip-
ped swab across the skin of their forehead, hairline, and eyebrows.
RCA
DNA was extracted from swab specimens using QIAquick PCR purification
columns (QIAGEN). The purified DNA was digested with NotI or SalI-HF
(NEB) and Plasmid Safe (exonuclease V, Epicentre) and then ethanol precipi-
tated. The pelleted DNA was redissolved and amplified using an Illustra
TempliPhi RCA kit (GE Healthcare). Additional details are given in the Supple-
mental Experimental Procedures and at our laboratory website (http://home.
ccr.cancer.gov/LCO/).
PCR
PCR primers and cycling parameters are given in the Supplemental Experi-
mental Procedures.
Sequence Analyses
GenBank accession numbers for the full-length viral genomes reported in this
work are HM011538–HM011570. Sequence analysis was performed using514 Cell Host & Microbe 7, 509–515, June 17, 2010 ª2010 Elsevier InMacVector 11 software. Neighbor-joining phylogenetic trees for nucleotide
sequences were constructed from ClustalW alignments using Kimura’s two-
parameter distance method. Protein analyses were aligned by Gonnet series,
and trees were constructed using uncorrected (‘‘p’’) without bootstrapping.
Trees were displayed using FigTree 1.2 software (http://tree.bio.ed.ac.uk/
software/figtree/). Accession numbers for polyomavirus sequences used to
construct phylogenetic trees are provided in the Supplemental Experimental
Procedures.Virion and VP1 Particle Isolation
Virions and VLPs were extracted from sets of skin swabs from 9–11 individuals
or lysates of roughly 23 108 293TT cells transfected for 1–2 weeks with recon-
stituted MCV isolate R17a genomic DNA. VLPs and subviral particles were
produced by transfecting 293TT cells with VP1 expression plasmids pwP,
pwM(Tolstovet al., 2009), p6VP1,or p7VP1 carrying, respectively, codon-modi-
fied versions of MPyV, MCV, HPyV6, or HPyV7 VP1. In all instances, the extrac-
tion buffer was composed of Dulbecco’s PBS supplemented with Triton X-100
and Benzonase Endonuclease (Sigma). A previously reported Optiprep velocity/
density ultracentrifuge gradient method was used to purify virions and VP1
particles away from other extract components (Buck and Thompson, 2007).
Additional details are given in the Supplemental Experimental Procedures.VP1 Stripping
Samples of pooled Optiprep gradient fractions were diluted in phosphate buffer
and then treated with a mixture of MCV VP1-specific IgM mAbs MV32 and
MV62 (D.V.P., K.A.P., N. C¸uburu, R.M.S., and C.B.B., unpublished data). An
anti-sarcomeric actin IgM mAb (Invitrogen) was used as an isotype control.
Antibodies were stripped out of solution using anti-IgM magnetic beads (Dynal,
Invitrogen). The supernatant was digested with Proteinase K, then subjected to
ethanol precipitation and analyzed by MCV-specific qPCR. Additional details
are given in the Supplemental Experimental Procedures.ACCESSION NUMBERS
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